American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 913 | 2,218 | 4,147 | 3,655 | 3,872 |
| Cost of Goods | 1,106 | 1,670 | 2,909 | 2,471 | 2,584 |
| Gross Profit | -193 | 548 | 1,238 | 1,184 | 1,288 |
| Operating Expenses | 1,245 | 2,397 | 2,768 | 2,248 | 2,634 |
| Operating Income | -1,332 | -1,179 | -621 | -593 | -762 |
| Interest Expense | 194 | 194 | 175 | 265 | 284 |
| Other Income | 118 | 912 | 2 | 172 | 20 |
| Pre-tax Income | -1,408 | -461 | -794 | -686 | -1,026 |
| Income Tax | 2 | 2 | 2 | -5 | 2 |
| Net Income Continuous | -1,410 | -463 | -796 | -681 | -1,028 |
| Net Income | $-1,410 | $-463 | $-796 | $-681 | $-1,028 |
| EPS Basic Total Ops | -0.03 | -0.01 | -0.02 | -0.02 | -0.03 |
| EPS Basic Continuous Ops | -0.03 | -0.01 | -0.02 | -0.02 | -0.03 |
| EPS Diluted Total Ops | -0.03 | -0.01 | -0.02 | -0.02 | -0.03 |
| EPS Diluted Continuous Ops | -0.03 | -0.01 | -0.02 | -0.02 | -0.03 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -0.02 | -0.02 | -0.03 |
| EBITDA(a) | $-1,281 | $-1,111 | $-525 | $-404 | $-555 |